Piermont Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $1.34M | Buy |
|
|||||
|
2018
Q3 | $1.65M | Sell |
|
|||||
|
2018
Q2 | $1.44M | Buy |
|
|||||
|
2018
Q1 | $2.15M | Buy |
|
|||||
|
2017
Q4 | $2.06M | Sell |
|
|||||
|
2017
Q3 | $2.31M | Hold |
|
|||||
|
2017
Q2 | $1.97M | Sell |
|
|||||
|
2017
Q1 | $2.17M | Sell |
|
|||||
|
2016
Q4 | $2.62M | Sell |
|
|||||
|
2016
Q3 | $2.73M | Sell |
|
|||||
|
2016
Q2 | $4.32M | Buy |
|
|||||
|
2016
Q1 | $613K | Sell |
|
|||||
|
2015
Q4 | $534K | Sell |
|
|||||
|
2015
Q3 | $485K | Hold |
|
|||||
|
2015
Q2 | $503K | Sell |
|
|||||
|
2015
Q1 | $648K | Buy |
|
|||||
|
2014
Q4 | $423K | Sell |
|
|||||
|
2014
Q3 | $386K | Buy |
|
|||||
|
2014
Q2 | $270K | Hold |
|
|||||
|
2014
Q1 | $240K | Hold |
|
|||||
|
2013
Q4 | $222K | Buy |
|